The impact of EBV load on T-cell immunity in pediatric thoracic transplant recipients

Transplantation

Volumn 88, Issue 1, 2009, Pages 123-128

  Macedo, Camila ^a   Zeevi, Adriana ^a,b   Bentlejewski, Carol ^b   Popescu, Iulia ^a   Green, Michael ^c   Rowe, David ^d   Smith, Louise ^c   Webber, Steve ^c   Metes, Diana ^a,b  

^a UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^c CHILDREN S HOSPITAL OF PITTSBURGH   (United States)

^d UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

Cylex Immuknow; EBV; Pediatric; Solid organ transplantation; T cell immunity

Indexed keywords

ADENOSINE TRIPHOSPHATE; CONCANAVALIN A; PHYTOHEMAGGLUTININ; VIRUS ANTIBODY; VIRUS DNA;

ADOLESCENT; ADULT; ARTICLE; CD4+ T LYMPHOCYTE; CELLULAR IMMUNITY; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; EPSTEIN BARR VIRUS; FEMALE; HEART LUNG TRANSPLANTATION; HEART TRANSPLANTATION; HUMAN; IMMUNOCOMPETENCE; LUNG TRANSPLANTATION; LYMPHOPROLIFERATIVE DISEASE; MALE; PEDIATRIC SURGERY; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; THORAX SURGERY; VIRUS LOAD; ALLOTRANSPLANTATION; BLOOD; CELL CULTURE; COMPARATIVE STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; GENETICS; IMMUNOLOGICAL MEMORY; IMMUNOLOGY; ISOLATION AND PURIFICATION; METABOLISM; POLYMERASE CHAIN REACTION; PRESCHOOL CHILD; VIROLOGY; VIRUS INFECTION;

ADENOSINE TRIPHOSPHATE; ADOLESCENT; ANTIBODIES, VIRAL; CD4-POSITIVE T-LYMPHOCYTES; CELLS, CULTURED; CHILD; CHILD, PRESCHOOL; DNA, VIRAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; EPSTEIN-BARR VIRUS INFECTIONS; FEMALE; HEART TRANSPLANTATION; HEART-LUNG TRANSPLANTATION; HERPESVIRUS 4, HUMAN; HUMANS; IMMUNITY, CELLULAR; IMMUNOLOGIC MEMORY; LUNG TRANSPLANTATION; LYMPHOPROLIFERATIVE DISORDERS; MALE; POLYMERASE CHAIN REACTION; TRANSPLANTATION, HOMOLOGOUS; VIRAL LOAD; YOUNG ADULT;

EID: 67651049212     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0b013e3181aacdd7     Document Type: Article

References (26)

1. Webber SA, Naftel DC, Fricker FJ, et al. Lymphoproliferative disorders after paediatric heart transplantation: A multi-institutional study. Lancet 2006; 367: 233.
2. Russo LM, Webber SA. Pediatric heart transplantation: Immunosuppression and its complications. Curr Opin Cardiol 2004; 19: 104.
3. Webber SA, McCurry K, Zeevi A. Heart and lung transplantation in children. Lancet 2006; 368: 53.
4. Green M, Webber SA. Persistent increased Epstein-Barr virus loads after solid organ transplantation: Truth and consequences? Liver Transpl 2007; 13: 321.
5. Qu L, Green M, Webber S, et al. Epstein-Barr virus gene expression in the peripheral blood of transplant recipients with persistent circulating virus loads. J Infect Dis 2000; 182: 1013.
6. Bingler MA, Feingold B, Miller SA, et al. Chronic high Epstein-Barr viral load state and risk for late-onset posttransplant lymphoproliferative disease/lymphoma in children. Am J Transplant 2008; 8: 442.
7. Tsai DE, Douglas L, Andreadis C, et al. EBV PCR in the diagnosis and monitoring of posttransplant lymphoproliferative disorder: Results of a two-arm prospective trial. Am J Transplant 2008; 8: 1016.
8. Batal I, Zeevi A, Heider A, et al. Measurements of global cell-mediated immunity in renal transplant recipients with BK virus reactivation. Am J Clin Pathol 2008; 129: 587.
9. Zeevi A, Husain S, Spichty KJ, et al. Recovery of functional memory T cells in lung transplant recipients following induction therapy with alemtuzumab. Am J Transplant 2007; 7: 471.
10. Thai NL, Blisard D, Tom K, et al. Pancreas transplantation under alemtuzumab (Campath-1H) and tacrolimus: Correlation between low T-cell responses and infection. Transplantation 2006; 82: 1649.
11. Kowalski RJ, Post DR, Mannon RB, et al. Assessing relative risks of infection and rejection: A meta-analysis using an immune function assay. Transplantation 2006; 82: 663.
12. Zeevi A, Britz JA, Bentlejewski CA, et al. Monitoring immune function during tacrolimus tapering in small bowel transplant recipients. Transpl Immunol 2005; 15: 17.
13. Kowalski R, Post D, Schneider MC, et al. Immune cell function testing: An adjunct to therapeutic drug monitoring in transplant patient management. Clin Transplant 2003; 17: 77.
14. Bhorade SM, Janata K, Vigneswaran WT, et al. Cylex Immu Know assay levels are lower in lung transplant recipients with infection. J Heart Lung Transplant 2008; 27: 990.
15. Lee TC, Goss JA, Rooney CM, et al. Quantification of a low cellular immune response to aid in identification of pediatric liver transplant recipients at high-risk for EBV infection. Clin Transplant 2006; 20: 689.
16. Wadowsky RM, Laus S, Green M, et al. Measurement of Epstein-Barr virus DNA loads in whole blood and plasma by TaqMan PCR and in peripheral blood lymphocytes by competitive PCR. J Clin Microbiol 2003; 41: 5245.
17. Hooper E, Hawkins DM, Kowalski RJ, et al. Establishing pediatric immune response zones using the Cylex Immu Know assay. Clin Transplant 2005; 19: 834.
18. Allen UD, Farkas G, Hebert D, et al. Risk factors for post-transplant lymphoproliferative disorder in pediatric patients: A case-control study. Pediatr Transplant 2005; 9: 450.
19. Lee TC, Savoldo B, Barshes NR, et al. Use of cytokine polymorphisms and Epstein-Barr virus viral load to predict development of post-transplant lymphoproliferative disorder in paediatric liver transplant recipients. Clin Transplant 2006; 20: 389.
20. Toyoda M, Moudgil A, Warady BA, et al. Clinical significance of peripheral blood Epstein-Barr viral load monitoring using polymerase chain reaction in renal transplant recipients. Pediatr Transplant 2008; 12: 778.
21. Smets F, Latinne D, Bazin H, et al. Ratio between Epstein-Barr viral load and anti-Epstein-Barr virus specific T-cell response as a predictive marker of posttransplant lymphoproliferative disease. Transplantation 2002; 73: 1603.
22. Thorley-Lawson DA, Gross A. Persistence of the Epstein-Barr virus and the origins of associated lymphomas. N Engl J Med 2004; 350: 1328.
23. Young LS, Rickinson AB. Epstein-Barr virus: 40 years on. Nat Rev Cancer 2004; 4: 757.
24. Thorley-Lawson DA. EBV the prototypical human tumor virus - Just how bad is it? J Allergy Clin Immunol 2005; 116: 251.
25. + T cells of pediatric kidney transplant recipients. Pediatr Transplant (Epub ahead of print).
26. Sampson VB, Dunn SP, Rymeski B, et al. Failure of immunosuppressive drug levels to predict T-cell reactivity in pediatric transplant patients. J Pediatr Surg 2008; 43: 1134.